King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Faculty of Health Sciences, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Clin Chem Lab Med. 2020 Jul 28;58(8):1302-1313. doi: 10.1515/cclm-2019-1049.
Background This is a second part of report on the IFCC global multicenter study conducted in Saudi Arabia to derive reference intervals (RIs) for 20 immunoassay analytes including five tumor makers, five reproductive, seven other hormones and three vitamins. Methods A total of 826 apparently healthy individuals aged ≥18 years were recruited in three clinical laboratories located in western, central and eastern Saudi Arabia using the protocol specified for the global study. All serum specimens were measured using Abbott, Architect analyzers. Multiple regression analysis (MRA) was performed to explore sources of variation of each analyte: age, body mass index (BMI), physical exercise and smoking. The magnitude of variation of reference values (RVs) attributable to sex, age and region was calculated by ANOVA as a standard deviation ratio (SDR). RIs were derived by the parametric (P) method. Results MRA revealed that region, smoking and exercise were not relevant sources of variation for any analyte. Based on SDR and actual between-sex differences in upper limits (ULs), we chose to partition RIs by sex for all analytes except for α-fetoprotein and parathyroid hormone (PTH). Age-specific RIs were required in females for ferritin, estradiol, progesterone, testosterone, follitropin, luteotropin and prolactin (PRL). With prominent BMI-related increase, RIs for insulin and C-peptide were derived after excluding individuals with BMI > 32 kg/m2. Individuals taking vitamin D supplements were excluded in deriving RIs for vitamin D and PTH. Conclusions RIs of major immunoassay analytes specific for Saudi Arabians were established in careful consideration of various biological sources of variation.
这是在沙特阿拉伯进行的 IFCC 全球多中心研究的报告第二部分,旨在为包括五种肿瘤标志物、五种生殖激素、七种其他激素和三种维生素在内的 20 种免疫分析物推导参考区间 (RI)。
在沙特阿拉伯西部、中部和东部的三个临床实验室,按照全球研究指定的方案,共招募了 826 名年龄≥18 岁的明显健康个体。所有血清标本均使用雅培、Architect 分析仪进行测量。采用多元回归分析 (MRA) 探索每个分析物的变异来源:年龄、体重指数 (BMI)、体育锻炼和吸烟。通过方差分析 (ANOVA) 计算性别、年龄和地区对参考值 (RV) 变异的影响程度,以标准偏差比 (SDR) 表示。RI 采用参数 (P) 法推导。
MRA 表明,地区、吸烟和运动不是任何分析物变异的相关来源。根据 SDR 和实际上限 (UL) 之间的性别差异,我们选择除甲胎蛋白和甲状旁腺激素 (PTH) 外,所有分析物均按性别划分 RI。铁蛋白、雌二醇、孕酮、睾酮、卵泡刺激素、黄体生成素和催乳素 (PRL) 等女性分析物需要特定年龄的 RI。由于与 BMI 相关的显著增加,胰岛素和 C 肽的 RI 在排除 BMI>32kg/m2 的个体后推导得出。在推导维生素 D 和 PTH 的 RI 时,排除了服用维生素 D 补充剂的个体。
在仔细考虑各种生物学变异来源的基础上,为沙特阿拉伯人建立了主要免疫分析物的 RI。